Stay updated on Pembrolizumab with BCG in HR NMIBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with BCG in HR NMIBC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    Change Detected
    Summary
    The value (Estimated) has recently changed to . The change represents an update in the estimated primary completion date and study completion date for the clinical trial evaluating the efficacy and safety of pembrolizumab in combination with Bacillus Calmette-Guerin (BCG) in participants with high-risk non-muscle invasive bladder cancer.
    Difference
    0.0%
    Check dated 2024-05-14T05:51:19.000Z thumbnail image
  6. Check
    8 days ago
    Change Detected
    Summary
    The value on the webpage has changed from '04 22 Recruiting Contact : Study Coordinator 318-683-0411 660001 Nasz Lekarz Przychodnie 04 19 04 22 04' to '05 10 Completed 661001 MICS Centrum Torun 05 09 (Estimated) 05 10 05'. This change represents a shift from a recruiting status to a completed status for the study involving Medical and healthcare-related publications and documentation.
    Difference
    0.5%
    Check dated 2024-05-10T16:03:07.000Z thumbnail image
  7. Check
    18 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2024-04-30T23:24:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with BCG in HR NMIBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with BCG in HR NMIBC Clinical Trial page.